INTERNATIONAL PATENT: ACTINIUM PHARMACEUTICALS, INC. FILES APPLICATION FOR "ANTI-TROP2 ANTIBODY RADIOCONJUGATES AND METHODS OF USE THEREOF"

GENEVA, March 19 -- ACTINIUM PHARMACEUTICALS, INC. (100 Park Avenue, 23rd FloorNew York, New York 10017) filed a patent application (PCT/US2025/045379) for "ANTI-TROP2 ANTIBODY RADIOCONJUGATES AND METHODS OF USE THEREOF" on Sep 08, 2025. With publication no. WO/2026/055611, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SETH, Sandesh (100 Park Avenue, 23rd FloorNew York, New York 10017), ROY, Monideepa (100 Park Avenue, 23rd FloorNew York, New York 10017)

Abstract: Provided are antibody radioconjugates that bind to huma...